These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9385528)

  • 61. Treatment of central precocious puberty with an intranasal analogue of GnRH (Buserelin).
    Bourguignon JP; Van Vliet G; Vandeweghe M; Malvaux P; Vanderschueren-Lodeweyckx M; Craen M; Du Caju MV; Ernould C
    Eur J Pediatr; 1987 Nov; 146(6):555-60. PubMed ID: 3123239
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Effects of HPGA suppression on predicted adult height in girls with central precocious puberty].
    Tao YH; Zeng BH; Sharif N
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Oct; 17(10):1093-7. PubMed ID: 26483231
    [TBL] [Abstract][Full Text] [Related]  

  • 63. When to stop GnRH analog therapy: the experience of the Italian Study Group for Physiopathology of Puberty.
    Arrigo T; Cisternino M; Galluzzi F; Bertelloni S; Pasquino AM; Antoniazzi F; Borrelli P; Crisafulli G; Wasniewska M; De Luca F
    J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():759-64. PubMed ID: 10969918
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Adult height comparison between boys and girls with precocious puberty after long-term gonadotrophin-releasing hormone analogue therapy.
    Galluzzi F; Salti R; Bindi G; Pasquini E; La Cauza C
    Acta Paediatr; 1998 May; 87(5):521-7. PubMed ID: 9641733
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Diagnostic differentiation between precocious puberty and premature thelarche using ultrasonography and the stimulated LH/FSH quotient].
    Pelzer V; Von Ditfurth M; Wendel U
    Geburtshilfe Frauenheilkd; 1990 Dec; 50(12):964-8. PubMed ID: 2128288
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of combined treatment with gonadotropin releasing hormone analogue and growth hormone in patients with central precocious puberty who had subnormal growth velocity and impaired height prognosis.
    Saggese G; Pasquino AM; Bertelloni S; Baroncelli GI; Battini R; Pucarelli I; Segni M; Franchi G
    Acta Paediatr; 1995 Mar; 84(3):299-304. PubMed ID: 7780252
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Adequacy of a single unstimulated luteinizing hormone level to diagnose central precocious puberty in girls.
    Houk CP; Kunselman AR; Lee PA
    Pediatrics; 2009 Jun; 123(6):e1059-63. PubMed ID: 19482738
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation.
    Antoniazzi F; Zamboni G; Bertoldo F; Lauriola S; Mengarda F; Pietrobelli A; Tatò L
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1096-101. PubMed ID: 12629090
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation.
    Mansfield MJ; Beardsworth DE; Loughlin JS; Crawford JD; Bode HH; Rivier J; Vale W; Kushner DC; Crigler JF; Crowley WF
    N Engl J Med; 1983 Nov; 309(21):1286-90. PubMed ID: 6415479
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bone age at discontinuation of medroxyprogesterone acetate therapy in girls with precocious puberty: effect on final height.
    Boulgourdjian E; Escobar ME; Martinez A; Heinrich JJ; Bergadá C
    Horm Res; 1995; 44(1):12-6. PubMed ID: 7649521
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diagnosis and treatment of central precocious puberty--can final height be improved? German/Dutch Central Precocious Puberty Study Group.
    Sippell WG
    Horm Res; 1994; 41 Suppl 2():14-5. PubMed ID: 8088698
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A mathematical model for predicting the adult height of girls with idiopathic central precocious puberty: A European validation.
    Lemaire P; Duhil de Bénazé G; Mul D; Heger S; Oostdijk W; Brauner R
    PLoS One; 2018; 13(10):e0205318. PubMed ID: 30300409
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function.
    Heger S; Partsch CJ; Sippell WG
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4583-90. PubMed ID: 10599723
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone.
    Pescovitz OH; Hench KD; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1988 Sep; 67(3):474-9. PubMed ID: 3137242
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty.
    Pasquino AM; Municchi G; Pucarelli I; Segni M; Mancini MA; Troiani S
    J Clin Endocrinol Metab; 1996 Mar; 81(3):948-51. PubMed ID: 8772556
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Improved final predicted height with the injection of leuprolide in children with earlier puberty: A retrospective cohort study.
    Lin YC; Lin CY; Chee SY; Yen HR; Tsai FJ; Chen CY; Wang CH
    PLoS One; 2017; 12(10):e0185080. PubMed ID: 28973010
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical and laboratory characteristics of children referred for early puberty: preponderance in 7-8 years of age.
    Kılıç A; Durmuş MS; Ünüvar E; Yıldız I; Aydın BK; Uçar A; Bundak R; Baş F; Darendeliler F; Oğuz F; Sıdal M; Yekeler E
    J Clin Res Pediatr Endocrinol; 2012 Dec; 4(4):208-12. PubMed ID: 23261863
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Time to menarche and final height after histrelin implant treatment for central precocious puberty.
    Gillis D; Karavani G; Hirsch HJ; Strich D
    J Pediatr; 2013 Aug; 163(2):532-6. PubMed ID: 23485026
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Final height and body disproportion in thalassaemic boys and girls with spontaneous or induced puberty.
    Filosa A; Di Maio S; Baron I; Esposito G; Galati MG
    Acta Paediatr; 2000 Nov; 89(11):1295-301. PubMed ID: 11106039
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A comparison of patients with premature thelarche and idiopathic true precocious puberty in the initial stage of illness.
    Aritaki S; Takagi A; Someya H; Jun L
    Acta Paediatr Jpn; 1997 Feb; 39(1):21-7. PubMed ID: 9124048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.